World Journal of Gastroenterology - Baishideng Publishing Group

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 30, Issue 16

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (1365)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-10) series, Tables (1-3) series.

Item

Count

PDF

HTML

975

Figures (1-10)

Tables (1-3)

Sum=1153

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

128

Sum=155

Apr 28, 2024 (publication date) through Jun 23, 2024

Times Cited of This Article

Times Cited (1)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Cited by in CrossRef

For:	Valibouze C, Dubuquoy C, Chavatte P, Genin M, Maquet V, Modica S, Desreumaux P, Rousseaux C. Chitin-glucan improves important pathophysiological features of irritable bowel syndrome. World J Gastroenterol 2024; 30(16): 2258-2271 [PMID: 38690023 DOI: 10.3748/wjg.v30.i16.2258]
URL:	https://www.wjgnet.com/1007-9327/full/v30/i16/2258.htm

Number	Citing Articles
1	Nathalie Talbodec, Pauline Le Roy, Peggy Fournier, Benoit Lesage, Elodie Lepoutre, François Castex, Jean Michel Godchaux, Lionel Vandeville, Benjamin Bismuth, Xavier Lesage, Pauline Bayart, Michael Genin, Christel Rousseaux, Veronique Maquet, Salvatore Modica, Pierre Desreumaux, Caroline Valibouze. Efficacy and tolerability of chitin-glucan combined with simethicone (GASTRAP<sup>®</sup> DIRECT) in irritable bowel syndrome: A prospective, open-label, multicenter study. World Journal of Gastrointestinal Pharmacology and Therapeutics 2024; 15(3): 90757 doi: 10.4292/wjgpt.v15.i3.90757 Abstract(53) \| Core Tip(59) \| Full Article(HTML)(561) \| Full Article with Cover (PDF)-1742K(10) \| Full Article (Word)-872K(0) \| Audio-343K(0) \| Peer-Review Report-271K(10) \| Answering Reviewers-361K(7) \| Full Article (PDF)-1432K(36) \| Full Article (XML)-118K(6) \| Times Cited (0) \| Total Visits (1144) \| Open

Number

Citing Articles

Nathalie Talbodec, Pauline Le Roy, Peggy Fournier, Benoit Lesage, Elodie Lepoutre, François Castex, Jean Michel Godchaux, Lionel Vandeville, Benjamin Bismuth, Xavier Lesage, Pauline Bayart, Michael Genin, Christel Rousseaux, Veronique Maquet, Salvatore Modica, Pierre Desreumaux, Caroline Valibouze. Efficacy and tolerability of chitin-glucan combined with simethicone (GASTRAP<sup>®</sup> DIRECT) in irritable bowel syndrome: A prospective, open-label, multicenter study. World Journal of Gastrointestinal Pharmacology and Therapeutics 2024; 15(3): 90757 doi: 10.4292/wjgpt.v15.i3.90757